Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Classified Sites

The Canadian Press - ONLINE EDITION

Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion

NEW YORK, N.Y. - The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.

Cadence, based in San Diego, focuses on the commercialization of products for use in hospitals. It makes Ofirmev, an injectable version of the drug acetaminophen, the active ingredient in Tylenol. Ofirmev has been used to treat an estimated 6 million to 7 million patients since its launch in January 2011.

"The acquisition of Cadence Pharmaceuticals is consistent with our goal of becoming a leading global specialty pharmaceuticals company," said CEO Mark Trudeau.

Shares of Cadence Pharmaceuticals Inc. surged $3.04, or 27.5 per cent, to $14.11 in premarket trading Tuesday.

Ireland's Mallinckrodt PLC will pay $14 per share, a 27 per cent premium to the Monday closing price of $11.07 for Cadence. The companies value the deal closer to $1.3 billion.

The boards of both companies have approved the deal that would make Cadence Pharmaceuticals Inc. a subsidiary at Mallinckrodt.

Mallinckrodt said Tuesday that it expects the acquisition, expected to close in March, to add to its adjusted earnings per share this year, and significantly add to adjusted earnings per share in 2015. .

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.


Make text: Larger | Smaller

Brandon Sun Business Directory
Submit a Random Act of Kindness
Why Not Minot?
Welcome to Winnipeg

Social Media

Canadian Mortgage Rates